HYNES CONVENTION CENTER

Boston, Massachusetts
March 8–11, 2020

 

Conference Dates and Location: 
March 4–7, 2018 | Boston, Massachusetts
Abstract Number: 
463

PHARMACOLOGIC MEASURES OF PrEP ADHERENCE AMONG HIGH-RISK MSM IN HPTN 067

Author(s): 

Jennifer Velloza1, Monica Gandhi2, Craig W. Hendrix3, Peter Bacchetti2, Pamela Murnane2, James P. Hughes1, Maoji Li4, Marcel Curlin5, Timothy H. Holtz6, Sharon Mannheimer7, Mark A. Marzinke3, K. Rivet Amico8, Estelle Piwowar-Manning3, Susan H. Eshleman3, Robert M. Grant9

1University of Washington, Seattle, WA, USA,2University of California San Francisco, San Francisco, CA, USA,3Johns Hopkins Hospital, Baltimore, MD, USA,4Fred Hutchinson Cancer Research Center, Seattle, WA, USA,5Oregon Health and Sciences University, Portland, OR, USA,6CDC, Atlanta, GA, USA,7Columbia University, New York, NY, USA,8University of Michigan, Ann Arbor, MI, USA,9Gladstone Institute of Virology and Immunology, San Francisco, CA, USA

Abstract Body: 

The effectiveness of oral emtricitabine (FTC)/tenofovir (TFV) disoproxil-fumarate pre-exposure prophylaxis (PrEP) is highly dependent on adherence. Given limitations of self-reported adherence, pharmacologic measures are useful for understanding patterns of adherence and identifying predictors of consistent PrEP use.

We analyzed data from HPTN 067, a trial of intermittent and daily PrEP completed in 2014. We included men who have sex with men (MSM) in Bangkok, Thailand, and Harlem, United States. Participants were randomly assigned to daily, time-driven (one dose twice/week plus one dose after sex), or event-driven (one dose before and after sex) oral PrEP regimens. Study visits occurred at weeks 0, 4, 12, and 24 post-randomization to assess FTC and TFV levels. Plasma and hair samples measured short and long-term drug exposure, respectively. Electronic pill bottle data (Wisepill™) were collected weekly. Potential predictors of adherence were measured at baseline (e.g., demographics, alcohol use) and longitudinally (e.g., sexual behavior). We estimated Pearson correlation coefficients among measures and assessed predictors of log-transformed plasma and hair drug levels using linear mixed models. Pharmacologic measures below the detection limit were set equal to that limit prior to log transformation.

Among the 350 randomized MSM at the two sites, half had completed college (N=179; 51.1%) and the median age was 31 years (IQR: 25–38 years). At baseline, 20.6% reported heavy alcohol use (N=72) and the median number of sex partners in the prior three months was 4 (IQR: 2–8). Across all arms and follow-up periods, FTC and TFV hair concentrations were moderately correlated with plasma concentrations and Wisepill™ data (Pearson coefficients >0.28). In multivariate models, being enrolled at the Harlem site, being in the time- or event-driven arms, and having less than college education were associated with lower hair FTC/TFV levels, while heavy alcohol use was associated with higher hair levels (Table). In models evaluating plasma levels, similar results were seen for site and study arm, but older age and greater number of sex partners were significantly associated with higher plasma drug levels.

In HPTN 067, plasma and hair drug concentrations and Wisepill™ data correlated with one another and served as complementary measures of PrEP adherence. Site, study arm, education, age, alcohol use, and sexual behavior influenced patterns of short and long-term PrEP adherence.

Session Number: 
P-F2
Session Title: 
PHARMACOLOGIC ASSESSMENT OF ADHERENCE
Presenting Author: 
Jennifer Velloza
Presenter Institution: 
University of Washington